Results reported October 1, 2026 | NYSE: ACN | IT services and consulting
The Quick Take
Accenture delivered a clean beat on revenue, EPS and bookings, and the stock jumped about 22% on the day, its largest one-day gain on record. The catch: FY2027 guidance implies organic growth of only about 0.5% to 4%, so much of the headline growth is being bought through acquisitions.
Results vs. Expectations
| Metric | Q4 FY2026 | Consensus | Result |
|---|---|---|---|
| Revenue | $18.68B (+7% local currency) | ~$18.03B | Beat |
| Diluted EPS | $3.29 | $3.18 | Beat |
| New bookings | $22.17B (+4% YoY) | n/a | Solid |
| Adjusted operating margin | 15.8% (+20 bps) | n/a | Expanding |
Full year FY2026: revenue $74.18B (+5% local currency), adjusted EPS $13.97 (+8%), free cash flow about $11.6B, and a record $11.5B returned to shareholders.
What Stood Out
- Record managed services bookings of $12.8B and a record 141 client contracts above $100M.
- Broad-based growth: all three geographic regions grew about 7% in the quarter.
- AI traction: nearly 400 clients started advanced AI work in the period.
- Cash returns: another $9.5B+ planned for FY2027, including $5.5B of buybacks and a 5% dividend increase.
FY2027 Guidance
| Item | Guidance |
|---|---|
| Revenue growth (local currency) | 3% to 6% |
| Inorganic contribution | ~2% to 2.5% |
| Implied organic growth | ~0.5% to 4% |
| Operating margin | 15.9% to 16.1% (+10 to 30 bps) |
| Diluted EPS | $14.39 to $14.81 |
| Free cash flow | $11.0B to $11.8B |
Risks
- Organic slowdown: the guidance midpoint implies weak underlying growth.
- Middle East drag of roughly $1B annualized revenue.
- Pricing pressure from intense competition and AI-driven efficiency, which can shrink billable work.
- Federal business weakness earlier this year triggered a guidance cut and a roughly 40% drawdown before this rebound.
- Sharp rally risk: after a 22% one-day pop, the stock needs follow-through; it is still down about 18% year to date.
Recommendation: HOLD (lean accumulate on pullbacks)
Execution was strong and the balance sheet and cash returns are excellent, but the best part of the surprise is now in the price. Existing holders can stay put. New buyers may prefer to wait for a pullback or for evidence that organic growth is accelerating toward the upper end of the range. A sustained slide in bookings or margin would change this view.
This is educational analysis, not personalized investment advice. Do your own research before investing.
Leave a comment